| Table of contents Rev. OFIL·ILAPHAR vol.30 n.4 Madrid Oct./Dec. 2020 Press Release | | | |
Editorials | | | | · COVID-19: revised healthcare paradigms Nombela, C
| | | | · Teleworking and telematic pharmaceutical care from the hospital pharmacy: how far can we go? Pérez Pons, JC
| | | | · The obvious before us Fernández, FJ
| | | | · The beginning of OFIL or a dream come true Ronda Beltrán, J
| | | Originals | | | | · Setting-up of a hospital outpatient Pharmaceutical Care Unit during the COVID-19 pandemic Seisdedos Elcuaz, R; Lomares Manzano, I; García Fernández, C
| | | | · Cystic fibrosis outpatient treatment and medical costs: a retrospective analysis Sánchez-Azofra, A; Calvo-García, A; Ruiz-García, S; Girón Moreno, RM; Ibáñez Zurriaga, MD; Aldave Orzaiz, B; Pastor Sanz, MT; Ancochea Bermúdez, J; Morell Baladrón, A
| | | | · Application of the Biopharmaceutical Classification System to the Basic Table of Medicines of Cuba: bioequivalence in vivo or dissolution in vitro? Miranda-Pérez de Alejo, C; Fernández-Cervera, M; Reyes-Naranjo, MI; Cabrera-Pérez, MA
| | | | · Economic impact and acceptance of electronic prescription and dispensing automation Prado-Mel, E; Jiménez-Guerrero, L; Seisdedos Elcuaz, R; Roldán Barrera, MG; Bautista Paloma, FJ
| | | | · Characterization of medication adherence in a sample of the general population and another of hypertensive patients in Panama Conte, E; Morales, Y; Niño, C; Zamorano, C; Benavides, M; Donato, M; Llorach, C; Gómez, B; Toro, J
| | | Review | | | | · Effectiveness and safety of immune ckeckpoint inhibitors on patients excluded from clinical trials Molinero Muñoz, M; Zamora Barrios, MD; Martínez Sesmero, JM
| | | Special Articles | | | | · CAR-T: lights and shades Notario Dongil, C; Fraga Fuentes, MD; Gómez Lluch, MT; Marcos de La Torre, A; Andrés Navarro, N; Valenzuela Gámez, JC
| | | | · An overview of pharmaceutical care in Mexico Lara-Aké, NJ
| | | Clinical Cases | | | | · Heart disorders in the context of hydroxychloroquine treatment for SARS-Cov2: a case report Díaz-Gago, A; Vélez-Díaz-Pallares, M; Mihaela-Pirlitu, A; Álvarez-Díaz, A
| | | | · Urea as a therapeutic alternative to tolvaptan in the treatment of hyponatremia: case report Ferrer-Machín, A; García-García, PM; Plasencia-García, I; Merino-Alonso, J
| | | | · Management of the drug interaction between rivastigmine and tolterodine in one elderly patient with Parkinson and overactive bladder Barranco Castañeda, G; Posada Galarza, MER; Oropeza Cornejo, R
| | | | · Pharmacokinetic monitoring of supratherapeutic adalimumab levels in patient with Crohn's disease Alañón Pardo, MM; Proy Vega, B; Roncero García-Escribano, O; Valenzuela Gámez, JC
| | | | · Multidisciplinary work model with results in health in the constitutional syndrome of the polymedicated elderly patient Hernández Rojas, S; Plasencia García, I; Bethencourt Feria, M; Merino Alonso, J
| | | Letters to the Editor | | | | · Clopidogrel genérico. ¿Peores resultados y mayores costes sanitarios? Los datos no dicen eso Sierra-Sánchez, JF; Bravo Toledo, R; González-Carrascosa Vega, T
| | | | · El farmacéutico hospitalario en tiempos de COVID-19 Gómez Lluch, MT
| | | | · Opioid analgesics available in Portugal approved for chronic pain Valentim Maricoto Silva, MF; Aguilar Abrantes Nogueira, GM
| | |
|